If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Maria Bareggi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Osteonecrosis Medicine & Life Sciences
Diphosphonates Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 474 Citations
  • 9 h-Index
  • 18 Article
  • 1 Chapter

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Gobbini, E., Chiari, R., Pizzutillo, P., Bordi, P., Ghilardi, L., Pilotto, S., Osman, G., Cappuzzo, F., Cecere, F., Riccardi, F., Scotti, V., Martelli, O., Borra, G., Maiello, E., Rossi, A., Graziano, P., Gregorc, V., Casartelli, C., Sergi, C., Del Conte, A. & 11 others, Delmonte, A., Bareggi, C., Cortinovis, D., Rizzo, P., Tabbò, F., Rossi, G., Bria, E., Galetta, D., Tiseo, M., Di Maio, M. & Novello, S., Jan 1 2019, (Accepted/In press) In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Retrospective Studies
Therapeutics
crizotinib
anaplastic lymphoma kinase
5 Citations (Scopus)

Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry

Bonaparte, E., Pesenti, C., Fontana, L., Falcone, R., Paganini, L., Marzorati, A., Ferrero, S., Nosotti, M., Mendogni, P., Bareggi, C., Sirchia, S. M., Tabano, S., Bosari, S. & Miozzo, M., Jan 12 2018, In : Diagnostic Pathology. 13, 1, 4.

Research output: Contribution to journalArticle

Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Lung Neoplasms
Mass Spectrometry
Biopsy
Mutation
23 Citations (Scopus)
23 Citations (Scopus)

Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and Asbestos-Exposed subjects suggest a 2-miRNA signature as potential biomarker of disease

Cavalleri, T., Angelici, L., Favero, C., DIoni, L., Mensi, C., Bareggi, C., Palleschi, A., Rimessi, A., Consonni, D., Bordini, L., Todaro, A., Bollati, V. & Pesatori, A. C., May 1 2017, In : PLoS One. 12, 5, e0176680.

Research output: Contribution to journalArticle

mesothelioma
asbestos
Asbestos
Biomarkers
MicroRNAs
8 Citations (Scopus)

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

Ganzinelli, M., Rulli, E., Caiola, E., Chiara Garassino, M., Broggini, M., Copreni, E., Piva, S., Longo, F., Labianca, R., Bareggi, C., Agnese Fabbri, M., Martelli, O., Fagnani, D., Cristina Locatelli, M., Bertolini, A., Valmadre, G., Pavese, I., Calcagno, A., Giuseppa Sarobba, M. & Marabese, M., Nov 17 2015, In : Scientific Reports. 5, 16331.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Disease-Free Survival
MicroRNAs
Survival